Skip to content
2000
Volume 30, Issue 12
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Given the importance of COVID-19-induced ARDS, recently, researchers have strived to determine underlying mechanisms involved in the inflammatory responses. In this regard, inflammasomes possess a distinct priority for cytokine storm occurrence and, subsequently, ARDS progression in ill patients with SARS-CoV-2 infection. In this minireview, the characteristics of known inflammasome inhibitors and designed research in this field were concretely deciphered.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867329666220906111550
2023-04-01
2025-07-05
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867329666220906111550
Loading

  • Article Type:
    Review Article
Keyword(s): ARDS; COVID-19; inflammasome; inhibitors; NLRP3; SARS-CoV-2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test